| Title |
Benefit–Risk Assessment of Blinatumomab in the Treatment of Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic Leukemia
|
|---|---|
| Published in |
Drug Safety, December 2018
|
| DOI | 10.1007/s40264-018-0760-1 |
| Pubmed ID | |
| Authors |
Anthony Stein, Janet L. Franklin, Victoria M. Chia, Deborah Arrindell, William Kormany, Jacqueline Wright, Mandy Parson, Hamid R. Amouzadeh, Jessica Choudhry, Guiandre Joseph |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| New Zealand | 1 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Science communicators (journalists, bloggers, editors) | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 99 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 99 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 15 | 15% |
| Researcher | 14 | 14% |
| Student > Ph. D. Student | 7 | 7% |
| Student > Master | 7 | 7% |
| Other | 6 | 6% |
| Other | 20 | 20% |
| Unknown | 30 | 30% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 22 | 22% |
| Biochemistry, Genetics and Molecular Biology | 16 | 16% |
| Pharmacology, Toxicology and Pharmaceutical Science | 9 | 9% |
| Nursing and Health Professions | 6 | 6% |
| Agricultural and Biological Sciences | 3 | 3% |
| Other | 10 | 10% |
| Unknown | 33 | 33% |
Attention Score in Context
This research output has an Altmetric Attention Score of 18. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 April 2024.
All research outputs
#2,074,590
of 25,738,558 outputs
Outputs from Drug Safety
#206
of 1,872 outputs
Outputs of similar age
#45,584
of 446,368 outputs
Outputs of similar age from Drug Safety
#3
of 27 outputs
Altmetric has tracked 25,738,558 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 91st percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,872 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.6. This one has done well, scoring higher than 88% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 446,368 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 89% of its contemporaries.
We're also able to compare this research output to 27 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 88% of its contemporaries.